ERAS protocol to shorten hospital stay after laparoscopic gynecologic surgery
Impact of Multimodal Analgesia and ERAS Protocol on Length of Hospital Stay After Laparoscopic Gynecological Surgeries: A Randomized Control Trial
This will test whether using an ERAS protocol with multimodal pain control shortens hospital stays for people having elective laparoscopic gynecologic surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 98 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | Female |
| Sponsor | Aga Khan University Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Trial ID | NCT07116564 on ClinicalTrials.gov |
What this trial studies
Adults with ASA physical status I–III scheduled for elective laparoscopic gynecological surgery at Aga Khan University will be assigned to receive multimodal analgesia with or without an Enhanced Recovery After Surgery (ERAS) protocol. The trial's primary outcome is length of hospital stay after the operation. Key exclusions include diagnostic laparoscopy, conversion to open surgery, severe anxiety or depression, and allergy or contraindication to the study drugs. This single-center, phase 4 interventional comparison will measure postoperative recovery and discharge timing between the ERAS and control groups.
Who should consider this trial
Good fit: Adults (ASA I–III) scheduled for elective laparoscopic gynecological surgery who can receive multimodal analgesia and consent to participate are the intended candidates.
Not a fit: Patients undergoing diagnostic laparoscopy, those whose procedure is converted to open surgery, those with severe anxiety or depression, or with contraindications to the study drugs are unlikely to benefit from the protocol.
Why it matters
Potential benefit: If successful, the ERAS protocol could shorten hospital stays and speed recovery after laparoscopic gynecologic procedures.
How similar studies have performed: ERAS programs have reduced length of stay across multiple surgical specialties, and there is growing evidence supporting benefit in gynecologic laparoscopic procedures.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA physical status I, II, and III * Patients scheduled for elective laparoscopic gynecological surgeries Exclusion Criteria: * Refusal to participate * History of allergy or contraindication to study drugs * Patients in which procedure converted to open surgery * Diagnostic laparoscopic procedures * Patients with a history of severe anxiety or depression
Where this trial is running
Karachi, Sindh
- Aga Khan University, Karachi, Pakistan — Karachi, Sindh, Pakistan (Recruiting)
Study contacts
- Study coordinator: Ali Sarfraz Siddiqui, MBBS, MCPS, FCPS, FIPP, MHPE
- Email: sarfraz.siddiqui@aku.edu
- Phone: +922134864397
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.